SARS-CoV-2, the virus that causes COVID-19, is an airborne disease transmitted via aerosols, which are spread from the oral and nasal cavities-;the mouth and the nose. In addition to the well-known division and spread of the virus in the cells of the respiratory tract, SARS-CoV-2 is also known to infect the cells of the lining … Read more
In a recent study posted to the medRxiv* preprint server, researchers in the Netherlands examined the role of inflammatory genes, cytotoxic T-lymphocytes (CD8+ T cells), and pro-inflammatory cytokines in long-lasting severe fatigue experienced by a large number of coronavirus disease 2019 (COVID-19) patients. Study: Severe fatigue as symptom of long COVID is characterized by increased … Read more
In a recently published article in the journal PLOS PATHOGENS, scientists have summarized acute and prolonged clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The review also provides an overview of the potency and utility of preclinical animal models to understand the mechanistic details of acute and long coronavirus disease 2019 (COVID-19). … Read more
Media Advisory Monday, August 29, 2022 What The amount of SARS-CoV-2 antigen measured in the blood of patients hospitalized with COVID-19 is associated with illness severity and other clinical outcomes, according to a new study published in the Annals of Internal Medicine. Following the ACTIV-3 trial of COVID-19 therapeutics in people hospitalized with COVID-19, researchers … Read more
In a recently published study British Medical Journal (BMJ)Researchers evaluated the efficacy of a fourth dose of vaccine against coronavirus disease 2019 (COVID-19) among long-term care residents. Study: Effectiveness of the fourth dose of the COVID-19 mRNA vaccine against the Omicron variant among long-term care residents in Ontario, Canada: a trial negative design study. Image … Read more